- Filed
- May 29, 2024 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 29, 2024 | 263.34M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 263.34M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 263.34M sh |
| Capex | Q1 2024 · Mar 31, 2024 | $41.61K |
| Capex | Q1 2024 · Mar 31, 2023 | $2.21K |
| Operating Cash Flow restated | Q1 2024 · Mar 31, 2024 | −$508.67K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$943.44K |
| Cash And Equivalents restated | Q1 2024 · Mar 31, 2024 | $2.88M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $3.16M |
| Stockholders Equity restated | Q1 2024 · Mar 31, 2024 | $69.22M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $69.19M |
| Current Liabilities restated | Q1 2024 · Mar 31, 2024 | $14.34M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $13.28M |
| Total Liabilities restated | Q1 2024 · Mar 31, 2024 | $14.41M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $13.34M |
| Current Assets restated | Q1 2024 · Mar 31, 2024 | $8.39M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $7.28M |
| Total Assets restated | Q1 2024 · Mar 31, 2024 | $82.99M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $81.95M |
| Net Income restated | Q1 2024 · Mar 31, 2024 | $24.57K |
| Net Income restated | Q1 2024 · Mar 31, 2024 | $24.57K |
| Net Income | Q1 2024 · Mar 31, 2023 | $649.06K |
| Net Income | Q1 2024 · Mar 31, 2023 | $649.06K |
| Operating Income restated | Q1 2024 · Mar 31, 2024 | −$16.4K |
| Operating Income | Q1 2024 · Mar 31, 2023 | $664.36K |
| Gross Profit | Q1 2024 · Mar 31, 2024 | $4.5M |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $3.93M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $5.91M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $5.29M |
| Revenue | Q1 2024 · Mar 31, 2024 | $10.4M |
| Revenue | Q1 2024 · Mar 31, 2023 | $9.22M |